Medical Design Technology

Surgery

Subscribe to Surgery

Researchers "Grow" New Blood Vessels

February 3, 2011 7:32 pm | by Massachusetts Institute of Technology | News | Comments

The synthetic vessels can be stored for long periods and avoid the complications typical of vessel grafts.

Ceregene Advances Phase 2b CERE-120 (AAV2-neurturin) Trial in Parkinson's Disease

February 3, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Feb. 3, 2011 /- Ceregene, Inc., a biopharmaceutical company, announced today that it is progressing with enrollment and dosing in its CERE-120 (AAV2-neurturin) Phase 2b multi-center, sham-surgery, double-blinded controlled trial in Parkinson's disease.  This trial was...

Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering

February 3, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J., Feb. 3, 2011 /- Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX ), an emerging specialty pharmaceutical company, today announced the pricing of its initial public offering of 6,000,000 shares of its common stock at $7.00 per share, before underwriting discounts and...

Advertisement

CareFusion to Sell International Surgical Products Distribution Business to Medline for $130 Million(2)

February 3, 2011 2:38 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO and MUNDELEIN, Ill., Feb. 3, 2011 /- CareFusion Corporation (NYSE: CFN ) a global, medical technology company, and Medline Industries, Inc. , the nation's largest privately held manufacturer and distributor of healthcare products, today announced an agreement to sell the...

San Antonio's Texas Institute of Dermatology, Laser and Cosmetics Adds Alma Lasers Harmony XL Cosmetic Laser to Offer Advanced Rejuvenation Treatments to Patients

February 1, 2011 7:38 am | by Bio-Medicine.Org | News | Comments

SAN ANTONIO, Feb. 1, 2011 /- Texas Institute of Dermatology, Laser and Cosmetics is now offering Alma Lasers AFT™ treatments to South Texas residents including San Antonio and Boerne area to treat superficial vascular and pigmented irregularities and to improve skin color. "I'm very...

Access MediQuip Names Prakash Patel Chief Executive Officer

February 1, 2011 7:38 am | by Bio-Medicine.Org | News | Comments

LAKE MARY, Fla., Feb. 1, 2011 /- Access MediQuip (AMQ), the nation's first and largest provider of surgical implant management solutions, announced the appointment of Prakash Patel, M.D. to chief executive officer. He currently serves as the company's chief operating and chief clinical...

Winner Medical Group Inc. to Host First Quarter 2011 Earnings Conference Call on Thursday, February 10, 2011 at 08:30 a.m. EST

January 31, 2011 1:32 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, Jan. 31, 2011 /PRNewswire-Asia/ -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner Medical" or the "Company"), a leading manufacturer of medical dressings, medical disposables and non-woven fabric made from 100% natural PurCotton® products in China, today announced...

Hologic Appoints Mark D. Myslinski as Senior Vice President and General Manager of Diagnostics

January 31, 2011 1:31 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., Jan. 31, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, is pleased to announce...

Advertisement

Accuray Announces Results for Second Quarter of Fiscal 2011

January 27, 2011 1:36 pm | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Jan. 27, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today financial results for the second quarter of fiscal year 2011, ended December 31, 2010. For the second quarter of fiscal 2011, Accuray reported total...

Surgical Information Systems Completes IHE North American Connectathon

January 27, 2011 1:36 pm | by Bio-Medicine.Org | News | Comments

ATLANTA, Jan. 27, 2011 /- Surgical Information Systems ("SIS"), a leader in perioperative information systems, announced today that it has successfully completed the healthcare industry's week-long interoperability testing event, Integrating the Healthcare Enterprise (IHE) Connectathon....

Varian Medical Systems Announces X-Ray Products Contract With Toshiba Medical Systems

January 27, 2011 4:31 am | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY, Jan. 27, 2011 /- Varian Medical Systems (NYSE: VAR ) today announced the execution of a three year, approximately $450 million contract for Varian to supply medical imaging subcomponents to Toshiba Medical Systems for integration into diagnostic imaging equipment for the...

Solos Endoscopy, Inc. Reports $90,005 in Sales Revenue for Fourth Quarter 2010

January 27, 2011 4:31 am | by Bio-Medicine.Org | News | Comments

BOSTON, Jan. 27, 2011 /- Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to announce that the Company generated revenues during the three months ended December 31, 2010 in the amount of $90,005. The revenue for the three month period is a result of instrument sales to over fifty Hospitals,...

Newly Published Data Demonstrates Caldolor® Significantly Reduces Pain and Morphine Use in Post-Operative Patients

January 27, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., Jan. 27, 2011 /- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the publication of data affirming the safety and efficacy of Caldolor® ( ibuprofen ) Injection in treating post-operative pain in hospitalized patients. A Phase III study published in...

Frost & Sullivan Recognizes Cohera Medical, Inc.® for Developing TissuGlu®, Its Pioneering Surgical Adhesive That Is Strong, Easy-To-Use, Biocompatible and Resorbable

January 25, 2011 4:31 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Jan. 25, 2011 /- Based on its recent analysis of the surgical adhesives market, Frost & Sullivan recognizes Cohera Medical, Inc. with the 2010 Frost & Sullivan Award for New Product Innovation of the Year Award for TissuGlu. With surgeons looking for better...

More and More Celebrities Are Embracing Hair Restoration

January 24, 2011 10:32 pm | by Bio-Medicine.Org | News | Comments

LONDON, Jan. 25, 2011 /- An interesting statistic: more than half (55%) of hair loss sufferers would be more inclined to consider having a hair transplant if celebrities or public figures were more open about hair restoration surgery, and men are more likely to be influenced than women...

Independent Clinical Research Confirms Clinical Efficacy and Cost-Effectiveness of the SurgiCount Safety-Sponge® System

January 18, 2011 5:42 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif. and DUBLIN, Ohio, Jan. 18, 2011 /- Results of a multi-year, independent clinical research study on retained surgical sponges published in the February edition of The Joint Commission Journal on Quality and Patient Safety show that the institution implementing the SurgiCount...

New Online Resource Available Specifically for Patients and Their Caregivers Following a Heart Stent Procedure

January 18, 2011 5:42 am | by Bio-Medicine.Org | News | Comments

PARSIPPANY, N.J. and INDIANAPOLIS, Jan. 18, 2011 /- Today, patient support group Mended Hearts, in partnership with Daiichi Sankyo, Inc. and Eli Lilly and Company, launched the Stent Hub – an online resource for acute coronary syndrome (ACS) patients who were treated with...

Carbylan BioSurgery Completes Enrollment in Key Clinical Feasibility Study of Hydros and Hydros TA in Patients With Pain From Knee Osteoarthritis; Core Patent Issued

January 5, 2011 2:35 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Jan. 5, 2011 /- Carbylan BioSurgery, Inc. announced today the completion of patient enrollment in their double-blinded, multi-center COR1.0 feasibility trial to evaluate the safety and effectiveness of two products - Hydros and Hydros TA Joint Therapies - in patients...

<i>How I See It: </i>Uncertainty in medical device industry

January 4, 2011 7:38 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

A recent development – the FDA's intention to rescind a 510(k) medical device registration held by ReGen Biologics Inc. – signals the FDA intends to broaden its regulatory powers, leaving companies in the medical device industry and those that invest in development of medical technologies...

Stryker Completes Acquisition of the Neurovascular Division of Boston Scientific

January 3, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

KALAMAZOO, Mich., Jan. 3, 2011 /- Stryker Corporation (NYSE: SYK ) announced today the closing of its previously announced acquisition of the assets of the Neurovascular division of Boston Scientific, the global leader in the approximately $900 million worldwide neurovascular market,...

New Hope for Saving Diabetic Foot from Amputation

December 24, 2010 1:31 pm | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Dec. 24, 2010 /- During ICMS (International Cellular Medicine Society www.cellmedicinesociety.org ) Annual International Congress on Regenerative and Cell Based Medicine Conference held on November 12, 2010 in Las Vegas, Nevada, it was announced that a patient with...

Zimmer Finalizes Acquisition of Chinese Orthopaedic Implant Leader Beijing Montagne Medical Device Co., Ltd.

December 21, 2010 4:33 am | by Bio-Medicine.Org | News | Comments

BEIJING, Dec. 21, 2010 /- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader in musculoskeletal care, today announced that it has completed the acquisition of Beijing Montagne Medical Device Co., Ltd.  The acquisition further enhances Zimmer's presence in the emerging Chinese...

PharMEDium Announces Propofol, Ready-to-Use, Single Patient, Syringe Service for Operating Room Anesthesia

December 20, 2010 8:34 am | by Bio-Medicine.Org | News | Comments

LAKE FOREST, Ill., Dec. 20, 2010 /- PharMEDium Services LLC, announced the addition of Propofol to its custom operating room anesthesia syringe preparation services.  PharMEDium is the first compounder to offer Propofol in a pre-labeled, single patient, ready-to-use, tamper evident...

Accuray Establishes Medical Affairs Function

December 17, 2010 9:33 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Dec. 17, 2010 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that the company has established a Medical Affairs function to accelerate CyberKnife data collection, utilization and referral patterns and to provide...

Microban International Announces Breakthrough in Antimicrobial Technologies for Medical Devices

December 16, 2010 9:36 am | by Bio-Medicine.Org | News | Comments

HUNTERSVILLE, N.C., Dec. 16, 2010 /- Hospital Acquired Infections (HAI's) are a serious health threat associated with over 100,000 deaths each year.  These secondary infections following surgery are a major contributor to increased healthcare costs; experts estimate they add in...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading